TrialPloS one2026

Nonmyeloablative pentostatin-cyclophosphamide preconditioning improves rates of engraftment in adults undergoing haploidentical HCT for sickle cell disease.

Emily Limerick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.